date:Aug 11, 2021
mary syringe in a similar way to the current antibiotics treatments. It can potentially reduce the use of antibiotics by up to 50 percent on this application alone.
Clinically backed efficacies
Imilac and its claims are backed by controlled clinical studies and independently published research on the pathophysiological benefits of bCNH treatments in dairy cows.
Clinical studies show bCNH has efficacy equal to or better than the currently used antibiotic treatments in specific indications, Isco